GlassScriptPhysician profile
Umadevi Muthyala
NPI 1023044765
$7,913.14
in general payments reported to CMS, 2019-2025
45 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,368 · 2020: $1,047 · 2021: $996 · 2022: $470 · 2023: $563 · 2024: $668 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,009 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.95 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,035.72 | 2019-2025 | Mounjaro, Zepbound, Lyumjev |
| Astrazeneca Pharmaceuticals LP | $683.58 | 2019-2022 | |
| Insulet Corporation | $644.71 | 2019-2025 | Omnipod |
| Novo Nordisk INC | $615.66 | 2019-2022 | |
| Amgen INC. | $504.41 | 2019-2025 | Evenity, Prolia, Prolia |
| Sanofi-Aventis U.S. LLC | $492.74 | 2019-2023 | |
| Abbott Laboratories | $412.93 | 2020-2025 | Freestyle Libre 3 |
| Valeritas, INC. | $265.55 | 2019 | |
| Corcept Therapeutics | $238.13 | 2019-2024 | Korlym |
| Mannkind Corporation | $229.94 | 2020-2025 | |
| Dexcom, INC. | $227.01 | 2019-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $188.67 | 2019-2024 | Tymlos |
| Merck Sharp & Dohme LLC | $181.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $172.50 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.05 | 2019-2025 | Jardiance |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umadevi Muthyala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.